You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 9,855,335


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,855,335 protect, and when does it expire?

Patent 9,855,335 protects TIGECYCLINE and is included in one NDA.

This patent has eight patent family members in eight countries.

Summary for Patent: 9,855,335
Title:Tigecycline composition for injection
Abstract: Disclosed is a tigecycline composition for injection, comprising the active component, tigecycline, and a propping agent. Also included is a stabilization agent. Also disclosed is a stable, pharmaceutically acceptable reconstitution liquid having freeze-dried tigecycline. The tigecycline composition for injection of the present invention has good redissolution, and can dissolve without intense shaking, thereby avoiding foams caused by intense shaking. Upon testing, the tigecycline composition and the tigecycline composition-diluted reconstitution liquid prepared in the present invention prove to have substantially lowered oxidation degradation and epimer generation and increased stability of the tigecycline preparation. Compared to the compositions currently in clinical use, the composition of the present invention can increase the treatment effect of tigecycline, avoid safety risks caused by lactose, is easy to produce and store, and has a clinical usage stability, satisfying the requirements for clinical medicine.
Inventor(s): Quin; Jihong (Shanghai, CN)
Assignee: GALENICUM HEALTH S.L. (Barcelona, ES)
Application Number:14/413,854
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 9,855,335: A Comprehensive Analysis

Introduction

Patents are a cornerstone of innovation, providing inventors and companies with exclusive rights to their inventions. Understanding the scope and claims of a patent is crucial for both the patent holders and those who may be affected by the patent. This article will delve into the details of United States Patent 9,855,335, exploring its claims, the patent landscape, and relevant legal and practical considerations.

What is United States Patent 9,855,335?

To begin, it is essential to identify the subject matter of the patent. United States Patent 9,855,335 is a specific patent that has been granted by the U.S. Patent and Trademark Office (USPTO). However, without direct access to the patent details in the provided sources, we will discuss the general process and key elements involved in analyzing a patent.

Patent Claims: The Heart of the Patent

What are Patent Claims?

Patent claims are the legal definitions of the invention, outlining what the inventor considers to be their unique contribution. These claims are critical because they define the scope of the patent protection[3].

Types of Claims

  • Independent Claims: These claims stand alone and define the invention without reference to other claims.
  • Dependent Claims: These claims refer back to and further limit the scope of an independent claim.
  • Method Claims: These describe a process or method.
  • Apparatus Claims: These describe a device or system.

Analyzing Claims

To analyze the claims of a patent like 9,855,335, one would typically start by identifying the independent claims, as these provide the broadest definition of the invention. Then, the dependent claims are examined to see how they narrow down the scope.

Patent Scope and Coverage

Cooperative Patent Classification (CPC)

The Cooperative Patent Classification (CPC) system is used to classify patents based on their subject matter. This system helps in identifying similar patents and understanding the broader technological area in which the patent resides[4].

Patent Term and Expiration

The patent term, typically 20 years from the filing date of the earliest non-provisional application, is crucial. Any extensions or adjustments, such as Patent Term Adjustments (PTA) due to USPTO delays, can affect the expiration date[1].

Legal Considerations: Obviousness-Type Double Patenting (ODP)

What is ODP?

Obviousness-Type Double Patenting (ODP) is a doctrine that prevents the issuance of multiple patents for the same invention or obvious variations of the same invention. This is particularly relevant in cases where multiple patents are derived from the same application or priority chain[1].

Impact on Patent Validity

If a patent is found to be unpatentable due to ODP, it can significantly impact its validity. For example, in the case of Cellect LLC, multiple patents were invalidated due to ODP because they were deemed obvious variants of earlier patents in the same family[1].

Practical Considerations: Patent Searching and Analysis

Tools for Patent Searching

Advanced patent searching tools, such as those provided by the USPTO and international databases like PATENTSCOPE, are essential for analyzing the patent landscape. These tools allow for full-text searching of patent grants and applications from various jurisdictions[4].

Datasets and Analytics

The USPTO also provides datasets, such as the Patent Claims Research Dataset, which contain detailed information on claims and their dependency relationships. These datasets can be used to analyze patent scope and trends[3].

Economic and Policy Implications

Economic Impact

Patents can have significant economic implications, both for the patent holder and for the broader industry. The validity and scope of a patent can influence investment, innovation, and competition.

Policy Considerations

Policy discussions, such as those around the establishment of a small claims patent court, highlight the need for efficient and accessible mechanisms for resolving patent disputes. This is particularly important for small inventors and businesses who may not have the resources to engage in lengthy and costly litigation[5].

Case Studies and Examples

Cellect LLC Case

The Cellect LLC case illustrates the complexities of ODP and its impact on patent validity. Here, multiple patents were invalidated because they were found to be obvious variants of earlier patents in the same family. This case underscores the importance of careful analysis during the patent prosecution process to avoid such issues[1].

Key Takeaways

  • Patent Claims: The core of a patent, defining the scope of protection.
  • Patent Scope: Determined by classification systems like CPC and affected by legal doctrines such as ODP.
  • Legal Considerations: ODP can invalidate patents if they are deemed obvious variations of earlier patents.
  • Practical Tools: Advanced searching tools and datasets are crucial for analyzing the patent landscape.
  • Economic and Policy Implications: Patents have significant economic and policy impacts, influencing innovation and competition.

FAQs

What are the main types of patent claims?

The main types of patent claims include independent claims, dependent claims, method claims, and apparatus claims.

How does the Cooperative Patent Classification (CPC) system help in patent analysis?

The CPC system helps in classifying patents based on their subject matter, making it easier to identify similar patents and understand the broader technological area.

What is Obviousness-Type Double Patenting (ODP), and how does it affect patent validity?

ODP is a doctrine that prevents the issuance of multiple patents for the same invention or obvious variations. If a patent is found to be unpatentable due to ODP, it can be invalidated.

What tools are available for advanced patent searching?

Tools such as the USPTO's Patent Public Search, PATENTSCOPE, and the Cooperative Patent Classification database are available for advanced patent searching.

Why is the establishment of a small claims patent court being discussed?

The establishment of a small claims patent court is being discussed to provide an efficient and accessible mechanism for resolving patent disputes, particularly for small inventors and businesses.

Sources

  1. In re Cellect - United States Court of Appeals for the Federal Circuit
  2. U.S. Patent and Trademark Office (USPTO) - USAGov
  3. Patent Claims Research Dataset - USPTO
  4. Advanced Patent Searching - Clemson University Library Guides
  5. U.S. Patent Small Claims Court - Administrative Conference of the United States (ACUS)

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,855,335

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Amneal TIGECYCLINE tigecycline POWDER;INTRAVENOUS 211158-001 Aug 2, 2018 AP RX No No ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 9,855,335

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
China2012 1 0078509Mar 22, 2012
PCT Information
PCT FiledApril 07, 2013PCT Application Number:PCT/CN2013/000397
PCT Publication Date:September 26, 2013PCT Publication Number: WO2013/139179

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.